We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

63 hedge funds and large institutions have $291M invested in Precision BioSciences in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 6

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

26% more funds holding

Funds holding: 50 → 63 (+13)

0.11% more ownership

Funds ownership: 1.35% → 1.46% (+0.11%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

18% less capital invested

Capital invested by funds: $357M → $291M (-$65.4M)

Holders
63
Holders Change
+13
Holders Change %
+26%
% of All Funds
1.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
17
Reduced
6
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$13M
2
BlackRock
BlackRock
New York
+$7.13M
3
DP
DSAM Partners
United Kingdom
+$6.93M
4
Wells Fargo
Wells Fargo
California
+$4.74M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.72M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$8.97M
2
CAM
Cormorant Asset Management
Massachusetts
-$4.19M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.15M
4
MIM
Monashee Investment Management
Massachusetts
-$3.14M
5
Millennium Management
Millennium Management
New York
-$3.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$926K +$290K +720 +45%
HCMT
27
Highland Capital Management (Texas)
Texas
$861K – – –
UBS Group
28
UBS Group
Switzerland
$832K +$718K +1,783 +575%
Charles Schwab
29
Charles Schwab
California
$637K +$645K +1,601 New
Northern Trust
30
Northern Trust
Illinois
$575K +$583K +1,448 New
Barclays
31
Barclays
United Kingdom
$533K +$540K +1,341 New
NIP
32
Nicholas Investment Partners
California
$527K +$242K +602 +83%
BFM
33
Boothbay Fund Management
New York
$523K +$530K +1,316 New
PPA
34
Parametric Portfolio Associates
Washington
$462K +$302K +750 +182%
MWNA
35
Marshall Wace North America
New York
$372K -$325K -808 -46%
Morgan Stanley
36
Morgan Stanley
New York
$302K +$306K +759 +25,300%
Goldman Sachs
37
Goldman Sachs
New York
$273K -$1.01M -2,513 -79%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$262K +$265K +659 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$187K +$189K +470 New
N
40
Nuveen
North Carolina
$180K +$182K +453 New
Deutsche Bank
41
Deutsche Bank
Germany
$156K +$159K +394 New
CSS
42
Cubist Systematic Strategies
Connecticut
$146K +$148K +368 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$123K +$125K +310 New
PA
44
Parallel Advisors
California
$111K +$113K +280 New
Citigroup
45
Citigroup
New York
$79K +$78.1K +194 +4,850%
AIG
46
American International Group
New York
$77K +$78.1K +194 New
EWM
47
Edge Wealth Management
New York
$53K +$53.5K +133 New
MA
48
MUFG Americas
New York
$51K +$51.5K +128 New
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$38K +$39.1K +97 New
JP Morgan Chase
50
JP Morgan Chase
New York
$33K -$503K -1,249 -94%
1
2
3 4

DTIL Hedge Fund Activity: Q2 2019 in Review

63 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2019, worth a combined $291M — down 18% from $357M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new DTIL positions and 16 closed out — a net gain of 13 holders — while 17 added to existing stakes and 6 trimmed.

The largest buyer was Franklin Resources, adding an estimated $13M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $8.97M sold.

  • 63 institutional investors held Precision BioSciences (DTIL) as of Q2 2019, up from 50 in Q1 2019.
  • Funds reported $291M of Precision BioSciences stock for Q2 2019, down 18% quarter-over-quarter.
  • 29 funds opened new Precision BioSciences positions in Q2 2019 and 16 closed out, a net change of +13 holders.
  • The largest Precision BioSciences buyer in Q2 2019 was Franklin Resources, an estimated $13M added.
  • The largest Precision BioSciences seller in Q2 2019 was Janus Henderson Group, an estimated $8.97M sold.

Based on aggregated 13F filings for Q2 2019.